← back to search

Francisco Javier Cubero

Universidad Complutense de Madrid · ES
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver physiology and pathology, Drug-Induced Hepatotoxicity and Protection, and Alcohol Consumption and Health Effects.
h-index
40
citations
5,253
works
210
NIH funding
primary concept
Medicine
email

Recent publications

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential
Gut 2025cited by 1position: middledoi
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
JHEP Reports 2023cited by 10position: middledoi
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
Cancers 2021cited by 7position: lastdoi
<p>Guidelines and Considerations for Metabolic Tolerance Tests in Mice</p>
Diabetes Metabolic Syndrome and Obesity 2020cited by 159position: middledoi
Dual Targeting of G9a and DNA Methyltransferase‐1 for the Treatment of Experimental Cholangiocarcinoma
Hepatology 2020cited by 66position: middledoi
Loss of c‐Jun N‐terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
Hepatology Communications 2020cited by 29position: firstdoi
Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease
Cell Death and Disease 2019cited by 24position: firstdoi
Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury
Scientific Reports 2017cited by 39position: middledoi
c-Jun N-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine
Mucosal Immunology 2017cited by 23position: middledoi
Functional role of CCL5/RANTES for HCC progression during chronic liver disease
Journal of Hepatology 2016cited by 87position: middledoi
Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury
Gastroenterology 2015cited by 106position: firstdoi
Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury
Journal of Hepatology 2014cited by 21position: firstdoi
Bone marrow-derived c-jun N-terminal kinase-1 (JNK1) mediates liver regeneration
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014cited by 8position: lastdoi
Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis
Gut 2013cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christian Trautwein · FH Aachen8 papers (2013–2023) · 6 papers (2013–2020)Roger J. Davis · University of Massachusetts Chan Medical School6 papers (2014–2023) · 5 papers (2013–2023)Maximilian Hatting · Harvard Stem Cell Institute4 papers (2013–2020)Nikolaus Gaßler · Ernst Abbe University of Applied Sciences Jena4 papers (2013–2017) · 3 papers (2014–2015)Michael Müller · University Hospital Schleswig-Holstein3 papers (2013–2015)Wei Hu · University of Florida3 papers (2013–2015) · 3 papers (2013–2015)Alain de Bruin · Utrecht University3 papers (2016–2020) · 3 papers (2015–2019) · 2 papers (2014–2017)Johannes Haybaeck · Innsbruck Medical University2 papers (2020–2023) · 2 papers (2020–2023)Gang Zhao · Shanghai Jiao Tong University2 papers (2013–2020)Frederik M. Schaefer · Charité - Universitätsmedizin Berlin2 papers (2014–2014) · 2 papers (2019–2020)Ali Canbay · Charité - Universitätsmedizin Berlin2 papers (2015–2017) · 2 papers (2015–2017)